Targeted Protein Degradation by Chimeric Small Molecules, PROTACs and SNIPERs

被引：35

作者：

Naito, Mikihiko ^{[1
]}

Ohoka, Nobumichi ^{[1
]}

Shibata, Norihito ^{[1
]}

Tsukumo, Yoshinori ^{[1
]}

机构：

[1] Natl Inst Hlth Sci, Lab Mol Target & Gene Therapy Prod, Kawasaki, Kanagawa, Japan

来源：

FRONTIERS IN CHEMISTRY | 2019年 / 7卷

基金：

日本学术振兴会;

关键词：

PROTAC; SNIPER; E3; modulator; ubiquitin; proteasome; protein degradation; SELECTIVE DEGRADATION; INDUCE DEGRADATION; KNOCKDOWN; UBIQUITINATION; INHIBITORS; DESIGN; LIGAND; TIR1;

D O I：

10.3389/fchem.2019.00849

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

Technologies that induce targeted protein degradation by small molecules have been developed recently. Chimeric small molecules such as Proteolysis Targeting Chimeras (PROTACs) and Specific and Non-genetic IAP-dependent Protein Erasers (SNIPERs), and E3 modulators such as thalidomides, hijack the cellular machinery for ubiquitylation, and the ubiquitylated proteins are subjected to proteasomal degradation. This has motivated drug development in industry and academia because "undruggable targets" can now be degraded by targeted protein degradation.

引用

页数：5

共 50 条

[1] Selective Degradation of Target Proteins by Chimeric Small-Molecular Drugs, PROTACs and SNIPERs
Ishikawa, Minoru
Tomoshige, Shusuke
Demizu, Yosuke
Naito, Mikihiko
PHARMACEUTICALS, 2020, 13 (04)
[2] Targeted protein degradation by PROTACs
Neklesa, Taavi K.
Winkler, James D.
Crews, Craig M.
PHARMACOLOGY & THERAPEUTICS, 2017, 174 : 138 - 144
[3] Small molecule PROTACs in targeted therapy: An emerging strategy to induce protein degradation
Xi, Meiyang
Chen, Yi
Yang, Hongyu
Xu, Huiting
Du, Kui
Wu, Chunlei
Xu, Yanfei
Deng, Liping
Luo, Xiang
Yu, Lemao
Wu, Yonghua
Gao, Xiaozhong
Cai, Tao
Chen, Bin
Shen, Runpu
Sun, Haopeng
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 174 : 159 - 180
[4] Recent progress in degradation of membrane proteins by PROTACs and alternative targeted protein degradation techniques
Chen, Siyu
Cui, Jingliang
Chen, Haiyan
Yu, Bo
Long, Sihui
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 262
[5] Major advances in targeted protein degradation: PROTACs, LYTACs, and MADTACs
Alabi, Shanique B.
Crews, Craig M.
JOURNAL OF BIOLOGICAL CHEMISTRY, 2021, 296 (296)
[6] Emerging targeted protein degradation tools for innovative drug discovery: From classical PROTACs to the novel and beyond
Zhong, Yue
Chi, Fanglian
Wu, Hanyu
Liu, Yunxiao
Xie, Zhancheng
Huang, Wenlong
Shi, Wei
Qian, Hai
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 231
[7] Development of Gilteritinib-Based Chimeric Small Molecules that Potently Induce Degradation of FLT3-ITD Protein
Ohoka, Nobumichi
Suzuki, Masanori
Uchida, Takuya
Tsuji, Genichiro
Tsukumo, Yoshinori
Yoshida, Masayuki
Inoue, Takao
Demizu, Yosuke
Ohki, Hitoshi
Naito, Mikihiko
ACS MEDICINAL CHEMISTRY LETTERS, 2022, 13 (12): : 1885 - 1891
[8] Targeted Protein Degradation by Small Molecules
Bondeson, Daniel P.
Crews, Craig M.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 57, 2017, 57 : 107 - 123
[9] Harmony of Protein Tags and Chimeric Molecules Empowers Targeted Protein Ubiquitination and Beyond
Lawer, Aggie
Schulz, Luke
Sawyer, Renata
Liu, Xuyu
CELLS, 2024, 13 (05)
[10] Targeted protein degradation in cancers: Orthodox PROTACs and beyond
Li, Jin
Chen, Xinxin
Lu, Aiping
Liang, Chao
INNOVATION, 2023, 4 (03):

← 1 2 3 4 5 →